Pulmatrix annual operating margin
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Pulmatrix's operating margin was −125.07% for fiscal 2024.
View full Pulmatrix company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −125.07% | +76.90 pp |
| 2023 | 2023-12-31 | −201.97% | +110.12 pp |
| 2022 | 2022-12-31 | −312.09% | +78.06 pp |
| 2021 | 2021-12-31 | −390.15% | −312.09 pp |
| 2020 | 2020-12-31 | −78.06% | +183.53 pp |
| 2019 | 2019-12-31 | −261.59% | +13071.74 pp |
| 2018 | 2018-12-31 | −13,333.33% | −8116.92 pp |
| 2017 | 2017-12-31 | −5,216.42% | −2238.45 pp |
| 2016 | 2016-12-31 | −2,977.96% | −1061.39 pp |
| 2015 · Dec 31 | 2015-12-31 | −1,916.57% | +661.84 pp |
| 2014 · Dec 31 | 2014-12-31 | −2,578.41% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −65,066.67% | −64965.62 pp |
| Q3 2024 | 2024-09-30 | −725.96% | −501.26 pp |
| Q2 2024 | 2024-06-30 | −380.22% | −163.79 pp |
| Q1 2024 | 2024-03-31 | 12.69% | +318.56 pp |
| Q4 2023 | 2023-12-31 | −101.04% | +152.18 pp |
| Q3 2023 | 2023-09-30 | −224.70% | +47.74 pp |
| Q2 2023 | 2023-06-30 | −216.43% | +126.09 pp |
| Q1 2023 | 2023-03-31 | −305.87% | +121.97 pp |
| Q4 2022 | 2022-12-31 | −253.22% | +633.40 pp |
| Q3 2022 | 2022-09-30 | −272.44% | +493.70 pp |
| Q2 2022 | 2022-06-30 | −342.52% | −171.76 pp |
| Q1 2022 | 2022-03-31 | −427.84% | −133.96 pp |
| Q4 2021 | 2021-12-31 | −886.62% | −752.92 pp |
| Q3 2021 | 2021-09-30 | −766.14% | −736.93 pp |
| Q2 2021 | 2021-06-30 | −170.76% | −137.22 pp |
| Q1 2021 | 2021-03-31 | −293.88% | −122.38 pp |
| Q4 2020 | 2020-12-31 | −133.70% | +127.75 pp |
| Q3 2020 | 2020-09-30 | −29.21% | +135.70 pp |
| Q2 2020 | 2020-06-30 | −33.54% | +3308.94 pp |
| Q1 2020 | 2020-03-31 | −171.51% | +3170.98 pp |
| Q3 2019 | 2019-09-30 | −261.45% | +1023.33 pp |
| Q2 2019 | 2019-06-30 | −164.91% | +6154.58 pp |
| Q4 2018 | 2018-12-31 | −3,342.48% | +1568.99 pp |
| Q1 2018 | 2018-03-31 | −3,342.48% | +107.52 pp |
| Q3 2017 | 2017-09-30 | −1,284.78% | +89.72 pp |
| Q4 2016 | 2016-12-31 | −6,319.49% | −4759.13 pp |
| Q3 2016 | 2016-09-30 | −4,911.48% | −4195.50 pp |
| Q2 2016 · Jun 30 | 2016-06-30 | −3,450.00% | +3208.24 pp |
| Q1 2016 · Mar 31 | 2016-03-31 | −1,374.49% | +1241.70 pp |
| Q4 2015 | 2015-12-31 | −1,560.36% | +7086.30 pp |
| Q2 2016 · Sep 30 | 2015-09-30 | −715.98% | — |
| Q1 2016 · Jun 30 | 2015-06-30 | −6,658.24% | — |
| Q4 2015 | 2015-03-31 | −2,616.19% | — |
| Q2 2015 | 2014-09-30 | −8,646.67% | — |
Over the last five reported fiscal years, Pulmatrix's operating margin increased from −261.59% to −125.07%, a change of +136.52 percentage points. The latest reported quarter, Q4 2024, shows −65,066.67%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulmatrix filings at SEC.gov ↗